Elanco Animal Health Inc

NYSE:ELAN   3:59:54 PM EDT
-0.12 (-0.38%)
4:00:00 PM EDT: $31.50 -0.02 (-0.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)14.87B
Current PEN/A
Forward PE 70.04
2yr Forward PE 34.26
See more stats
Estimates Current Quarter
Revenue$1.05 Billion
Adjusted EPS$0.10
See more estimates
10-Day MA$31.32
50-Day MA$30.43
200-Day MA$26.30
See more pivots

Elanco Animal Health Inc Stock, NYSE:ELAN

United States of America
Phone: 877-352-6261
Number of Employees: 5590


Elanco Animal Health Incorporated, an animal health company, develops, manufactures, and markets products for companion and food animals. The company offers companion animal disease prevention products, such as parasiticide products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications; vaccines, nutritional enzymes, and animal-only antibiotics; and a range of food animal products used in ruminant and swine production. It sells its products to third-party distributors; veterinarians; and food animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated has a research and development collaboration with AgBiome, Inc. to develop nutritional health products for swine. The company was founded in 1954 and is headquartered in Greenfield, Indiana.